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Inhalation Toxicity and Carcinogenicity of
1,3-Butadiene in Sprague-Dawley Rats
by P. E. Owen* and J. R. Glaistert
A 2-year inhalation study was conducted in Sprague-Dawley rats with 1,3-butadiene. Groups of 110 male
and 110 female rats inhaled 1,3-butadiene at 0, 1000, or 8000 ppm for 6 hr/day, 5days/week. Interim clinical
pathology, neuromuscular, and histopathology investigations were carried out. The studyterminated at20
to 25% survival (105 weeks for females, 111 weeks for males).
Following exposure to 1,3-butadiene there were no effects on hematology, blood chemistry, urine
analysis, and neuromuscular function that definitely could be associated with treatment. Treatment was
associated with changes in clinical condition, suppression of body weight gain, reduced survival, and
increasesincertainorganweightsandinbothcommonanduncommontumortypes.Althoughthebiological
interpretation ofthesignificance ofsomeofthetumortypes isequivocal, theevidence suggeststhatthetest
article is an oncogen to the rat under the conditions ofexposure used in this study, and the mechanism is
more likely to be an indirect effect through the endocrine system, rather than a direct effect through the
production ofreactive metabolites.
Introduction
As a result of 1,3-butadiene being one ofthe world's
major industrial chemicals and the conflicting evidence
in the scientific literature regarding the health effects
associatedwithexposuretoit, aprogramoftoxicological
investigation was initiated.
As part of this investigation, a long-term inhalation
study in Sprague-Dawley rats was carried out, since no
long-term animal data were available at the time of
initiation. Apreliminary 90-dayexperiment in Sprague-
Dawley rats established exposure levels for the long-
tern study. That study used carefully specified 1,3-bu-
tadiene and an exposure systemthat had been shown to
give an even distribution throughout the exposure
chambers. (2) Despite awide range ofobservations, the
overall conclusion was that there were no treatment-
related effects at concentrations up to 8000 ppm v/v.
Exposure levels forthe long-term study were therefore
established as 0, 1000, or 8000 ppm v/v.
Study Design
Three 8-m3 exposure chambers ofglass and stainless
steel were used for the study. Each chamber was lit by
flash-prooflights viatwo strip glass windows that were
inserted into the stainless steelroof Each chamberhad
a drain at the lowest point for cleaning purposes. The
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mainairflowintothechamberwasdrawnfromtheroom
through a filter (efficiency 95% at 1 ,um). The flow rate
was monitored by means of a pitot tube and inclined
manometer. The target flow rate was 1000 L/min for all
chambers. The chambers were operated at negative
pressure, and a separate alarm monitored the differ-
ential pressure between the inside and outside of the
chambers. The alarm was activated if the airflow rate
fellto alevelthatallowed the production ofanexplosive
atmosphere.
Each chamber had two sets ofadjustable runners for
easy loading ofthe cage racks. To avoid the build-up of
static the racks were connected by groundwire to the
chamber walls. The chambers also had direct ground
connections to a ground rod outside the building.
The temperature and relative humidity in the ex-
posure chambers were within the range of200C to 25°C
and 40 to 80% on 96% of the occasions that measure-
ments were made.
The generation and transfer of 1,3-butadiene gas to
theexposurechamberstookplaceinanall-stainless steel
system. To help volatilization, the 1,3-butadiene was
passed through a water bath at 300C. Following vol-
atilization the gas passed through traps to remove the
inhibitor, tertiarybutylcatechol. Theatmospheres were
routinelymonitored by aninfrared gas analyzer(Miran,
IA, Wilks Scientific Corporation, Ltd.) at hourly inter-
vals. The infrared analyzer was calibrated against a gas
chromatograph. An even distribution ofthe test article
was established in both exposure chambers before the
start ofanimal exposures and then confirmed atregular
intervals throughout the study.OWEN AND GLAISTER
Three groups of rats were exposed in the system
described for6 hr/day, 5 days/week for 105weeks inthe
case of females and 111 weeks for males at con-
centrations of 0, 1000, or 8000 ppm. There were 110
males and 110 females in each group: 10 males and 10
females from all groups were killed after 52 weeks; the
remainder, when survival was approximately 20%; each
sex was treated separately.
The low dose given was the thenthreshold limit value
(TLV) for occupationally exposed personnel. The high-
dose concentration was limited by the safety require-
ments to be below the lower explosive limit of 1,3-bu-
tadiene in air.
The animals used on the study were albino, hysterec-
tomy-derived, barrier-maintained rats ofthe CD strain
(Sprague-Dawley origin), obtained from Charles River,
UK. The average age of the young animals on arrival
was 3weeks, withbodyweightsrangingfrom40to 50 g.
Before treatment, ten weanlings ofeach sex and the
ten dams were killed and examined to confirmthattheir
health status was appropriate for a long-term toxicity
study. Samples from a nasopharyngeal swab, lower gut
contents, and a portion ofthe lower gut were examined
for the presence ofpotentially pathogenic bacteria. The
only bacterial flora was Staphylococcus aureus in the
nasopharynx of three of the animals. In the his-
topathological examinationparticularattention waspaid
tothe respiratory tract, butthere were nounacceptable
findings. It was concluded that the animals were appro-
priate for use in a long-term toxicity study.
During the acclimatization phase the experimental
group allocation was made with the use of a stratified
body weight randomization procedure designed to give
as near as possible equal group mean body weights and
standard deviations. Each animal selected for the dose
groups was identified by an individual ear tattoo.
The animals oflike sex were housed in groups offive
and were treated in stainless steel wire mesh cages that
were suspended onracks inthe exposure chambers. The
position ofthe racks in the chambers was interchanged
atweeklyintervals; atthe sametime, thepositionsofthe
cages on the racks were changed according to a pre-
determined plan.
Pelleted diet (SQC Rat and Mouse No. 1 Expanded,
BP Nutrition, Witham, Essex, England) and water
were available ad libitum during nonexposure periods
only. Ten batches of diet were used and, in addition to
thedataprovidedbythemanufacturer, sixofthese were
analyzed for nitrosamine and total organochlorine con-
tent. These diets contained 6 to 104 ,ugnitrosamines/kg
and 59 to 1100 ,ug total organochlorines/kg.
Test Material
Liquid 1,3-butadiene was supplied in pressurized cyl-
inders, each containing approximately 10 kg. Eight cyl-
inders were supplied (ICI Ltd., Wilton, England) each
week during the course of the study. During manu-
facture, liquid 1,3-butadiene was analyzed semi-
continuously. Analysis showed thatit complied withthe
specifications detailed in Table 1.
The gas supplied to the exposure chambers was ana-
lyzed each week for specific impurities: 4-vinyl-
1-cyclohexane (dimerization product) andtertiarybutyl-
catechol (inhibitor preventing polymerization). In gen-
eral, the concentration of 4-vinyl-1-cyclohexane was
below 500 ppm v/v, and the average of the weekly
measurements was413ppmv/v (SD = 219). Therewere
short intervals whenthe concentrations were above 500
ppmv/v, butprocedures wereintroduced to ensurethat
theanimalswerenotexposedtoatmospherescontaining
more than 1000 ppm v/v of the dimer in 1,3-butadiene.
The concentration of the inhibitor in the 1,3-butadiene
supply was less than 2 ppm v/v on most (93%) of the
analyses andbetween2.1 and4.8ppmv/vintheremain-
ing analyses. Also samples ofthe gas delivered into the
exposurechambersweresenttothesupplierforanalysis
to ensure there were no marked changes occurringdur-
ing generation.
Observations
All animals were observed twice daily, before and
after exposure, and a detailed observation with pal-
pation of superficial masses was performed at weekly
intervals. Individual body weights were recorded
weekly up to week 13, then every 2 weeks to week 52,
and monthly thereafter.
After exposure to the gas for 3, 6, 12, and 18 months
blood was withdrawn under light ether anesthesia from
the orbital sinus of 20 preselected animals of each sex
from each group. Before blood tests, the animals were
fasted for24 hr, but water was available duringthe last
18 hr ofthe fast. The blood was used to measure mean
cell volume and hemoglobin concentration, and for
counts of erythrocytes, leukocytes (total and differ-
ential), platelets and reticulocytes. Packed cell volume,
mean cell hemoglobin, and mean corpuscular hemo-
globin concentration were also calculated. In addition,
measurements were made of plasma concentrations of
glucose (sample taken from caudal vein), blood urea
nitrogen, total protein and protein electrophoresis, as
well as activities of alkaline phosphatase, glutamic-
oxaloacetic transaminase and glutamate-pyruvate
Table 1. Specification of the 1,3-butadiene used.
Parameter Value
1,3-Butadiene, % wt 99.2 min
Peroxides at H202, ppm wt 5.0 max
Acetylenes (as vinyl acetylene),
ppm wt 50.0 max
Sulfur, ppm wt 2.0 max
C5 hydrocarbons, % wt 0.1 max
Dimer content, % wt 0.05 max
Nonvolatile tnatter, ppm wt 500.0 max
Carbonyl content (as acetaldehyde),
ppm wt 25.0 max
Inhibitor, t-butylcatechol, ppm wt 75-150
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transaminase after exposure for3, 6, and 12months. At
12months, leukocyte counts (totalanddifferential)were
made in an additional ten animals ofeach sex from each
group, since a possible treatment-related effect had
been seen at the 6-month sampling in the high-dose
females.
Individualurine sampleswere obtained after3, 6, and
12 months' exposure. Wherever possible, the same 20
males and 20 females were sampled that were used for
the blood sampling. The urine samples were obtained
during a 4-hr period of food and water deprivation,
beginning approximately 2 hr after exposure. During
the 2-hr postexposure period all animals were given
access to water. The volume and specific gravity ofthe
urineweremeasuredandasemiquantitative assessment
was made for glucose, urobilinogen, ketones, bile pig-
ments, blood, protein, and pH. The insoluble con-
stituents of the urine were examined microscopically
after centrifugation.
The neuromuscular function of40 animals ofeach sex
fromeachdosegroupwasevaluatedbeforeandatweeks
1, 4, 15, 26, 52, and 78 of treatment. The time before
falling from arotating cone was recorded as an index of
neuromuscular function (1).
All animals were subjected to a postmortem exam-
ination. Animals that were to be killed because oftheir
poor condition or as a scheduled examination were not
given food but had water ad libitum overnight before
theywereanesthetized withsodiumpentobarbitone and
then exsanguinated.
The postmortem examination of animals killed at 52
weeks and atthe end ofthe studyincludedweighingthe
adrenal glands, brain, heart, kidneys, liver, lungs and
trachea, spleen and testes. All animals were examined
closelyforabnormalitiesandthetissuesamplesshownin
Table 2 were preserved in 10% neutral buffered
formalin.
The eyes were placed in Davidsons' fluid, not in for-
malin. Alltissues fromthe high-dose and controlgroups
were embedded in wax, sectioned (5 ,um), stained with
hematoxylin and eosin, and examined microscopically.
Fromthe low-dose group, the sections shown in Table 3
were prepared and examined.
Femoral marrow smears from all animals in the con-
trol and high-dose groups were examined, but the
different types of cells present in the smears were not
counted.
Transmission electron micrographs were prepared
from the livers for five animals of each sex from the
high-dose and control groups at termination. Samples
(from 10males and 11 females ofeachgroup-one extra
female was taken in error) were taken from the left
lateral lobe (the right was used if the left was visibly
abnormal), fixed in osmium, and embedded in epoxy
resin. Survey sections (1 ,um) were cut from the five
selected control and high-dose animals of each sex,
stained with 1% toluidine blue, and examined with the
light microscope. Centrilobular and periportal areas
were selected and ultrathin sections were prepared and
Table 2. Tissue samples examined.
Adipose tissue
Adrenal glands
Aorta
Liver (caudate, right median
and left lobe)
Lungs
Femur (including bone
marrow)
Brain
Cecum
Colon
Diaphragm
Ears (auditory canal and
pinna, with adjacent
sebaceous glands)
Epididymides
Eyes and optic nerve
Gonads
Harderian gland
Heart
Kidneys
Larynx
Spleen
Sternum
Stomach
Salivary gland
(submaxillary)
Mammary gland (full
thickness of abdominal
wall)
Esophagus (proximal to the
tongue)
Pancreas
Parathyroid
Pituitary
Prostate
Sciatic nerve
Seminal vesicle
Small intestine
Spinal cord (high cervical)
Thymus
Thyroid
Tongue
Trachea
Turbinate bones
Urinary bladder
Uterus
Skin (particularly any
showing lesions or
abnormalities of hair
growth) and vagina
All gross lesions
Lymph nodes
(tracheobronchial, cervical
and mesenteric)
Table 3. Sections examined from the low-dose group.
Brain Urinary bladder and Zymbal
Gonads gland of both sexes
Liver Salivary gland
Lungs Prostate
Lymph nodes (mesenteric) Seminal vesicles
Pancreas Epididymides and kidneys in
Spinal cord males and of pituitary
Thyroid gland
Spleen Mammary masses
Skin Uterus and vagina in
females
stained with uranyl acetate and lead citrate. The sec-
tions were examined and photographed with a Phillips
EM300 operating at 60 KV.
Statistical analysis ofthe data was undertaken using
thefollowingtestprocedures: survivaldataandpalpable
subcutaneous masses were analyzed by the methods of
Peto and Peto (8), Peto and Pike (9), and Kaplan and
Meier (10). Lesions/tumor incidences were analyzed ac-
cording to the method ofPeto et al. (11); body weights,
laboratory investigations, and organ weights were
analyzed by using analysis of variance and Student's
t-test (12).
Results and Evaluation
The daily mean concentration of 1,3-butadiene in the
control chamber did not exceed 3.0 ppm v/v on any
occasion, and the overall mean was 0.7 + 0.8 ppm v/v.
For the low-dose chamber, 94% of all daily mean con-
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centrations were within the range 1000 + 10% ppm v/v;
for the high-dose chamber, 96% of all recorded daily
mean concentrations were within the range 8000 ± 10%
ppm v/v. The respective means and SD over the course
ofthe study were 999.0 + 30.8 ppm v/v and 7886.0 ±
704.3 ppm v/v.
Anevendistributionof1,3-butadienethroughouteach
chamber was found when checked on five occasions.The
coefficients ofvariation based on 24 or27 sample points
for the low-dose chamber ranged between 9.19% and
15.69% and for the high-dose chamber, between 3.68%
and 7.63%.
Clinical signsthat appeared to berelated tothe treat-
ment were seen in the second until the fifth month of
exposure. Some rats in the high-dose group, especially
females, showedwetandruffledfurtogetherwithslight
limb weakness or incoordination during the first 3 hr of
the first exposure day of the week following 2 days
without treatment. During the remainder ofthe week,
these signs regressed.
There were only 16 deaths duringthe first yearofthe
study, but during the second year there was a statisti-
cally significant (10) (p < 0.05 in males; p < 0.01 in
NuaenL La
renag
females) relationship between increased mortality and
the concentration of1,3-butadiene (Figs. 1 and 2). Com-
parison ofthe individualtreated groups withthe control
showed a statistically significant difference (p
- 0.05 in
males; p
- 0.01 in females) only with the 8000 ppm v/v
group. Increased mortality in the female animals re-
sulted from the sacrifice of animals with large sub-
cutaneousmasses; inmales, renallesionswerethelikely
major cause ofthe increased death rate.
Over 80% ofthe subcutaneous masses in the females
proved to be mammary tumors; the remainder, fibrous
tumors ofthe skin. Statistical analysis showed that the
treated females were more likely to develop mammary
tumors than were the controls. The two doses did not
differ in this respect. The analysis showed that the
median time to develop a mass was 616 days in female
control animals, but 546 days in the low-dose group and
576 in the high-dose group.
The body weight gains ofboth sexes at the high dose
and of males at the low dose were slightly but signifi-
cantly lowerthan the controls duringthe first 12 weeks
ofthestudy. Thiswascompensated laterbyanincreased
gain, so that by the end ofthe first year the mean body
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FIGURE 2. Survival curves for female animals.
weights ofthe control and treated groups were similar.
From week 52 onward, there was no significant differ-
ence in weight gains for treated animals in comparison
with the controls.
Theonlyconsistentfindinginthehematological exam-
ination was higher leukocyte counts in the high-dose
females because of increased numbers of lymphocytes
during the first year (6.5 x 103/cmm at week 52). This
was not seen either at 78 weeks orin the males. In view
of this, and since the values were within the range
expected forthe strain ofanimals in this laboratory (6.4
to 9.6 x 103/mm3), they were not considered to be
toxicologically significant.
Blood urea nitrogen concentrations were statistically
significantly higher than controls in both treated male
groups at 13 (19.6 and 20.6 mg/dL compared with 17.1
mg/dL) and 26 weeks (16.7 mg/dL and 16.0 mg/dL,
compared with 13.5 mg/dL), but not at 52 weeks. The
corresponding values in females were lower than con-
trols (22.9 and 22.2 mg/dL, compared with 27.8 mg/dL)
atweek13and(18.6and 17.5mg/dL, comparedwith22.6
mg/dL) at week 26. Measurements of the volume and
specificgravityofurine collected at 13, 26, and52weeks
did not show any treatment-related effects.
Periodic tests for the neuromuscular coordination
showed no treatment-related effects in the first 6
months of the study. At 12 months, females from both
treated groups werelessablethanthecontrolstoremain
on the rotating cone; in part this may have been due to
the presence ofmammary masses that could have inter-
fered withthe mobility ofthe animals. Both sexes atthe
highdoseandfemalesatthelowdose werelessablethan
the controls to remain on the rotating cone when exam-
ined at 18 months. In addition, this observation was
made on animals soon after treatment and could not be
repeatedwithin 2 to 3 weeks whentested on adaywhen
the animals were not treated. This suggests that either
the effects were notreproducible or, ifthey were due to
exposure, recovery was rapid.
Table 4 lists the relative weights ofthose organs that
showed (12) a dose-related increase in either sex at
either 1 or2 years. Forcomparative purposesthe values
are expressed as a percentage ofthe control. The rela-
tive liver weights of both sexes and both dose levels
were elevated at the times of examination with the
exception of the high-dose females at week 52. There
780
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Table 4. Relative organ weights (g/100 g body weight).
Organ weight (% current control)
1 year 2 year
Male Female Male Female
1000 8000 1000 8000 1000 8000 1000 8000
Organ ppm v/v ppm v/v ppm v/v ppm v/v ppm v/v ppm v/v ppm v/v ppm v/v
Kidneys 104 102 104 102 104 124t 104 102
Liver 105* 124t 116* 110 lilt 125t 118t 121
Heart 96 100 103 103 104 116* 97 97
Lung 97 93 105 108 104 114* 106 103
Spleen 92 92 100 93 93 121* 107 133
Number examined 10 10 10 10 50 32 32 24
*Statistically significant p 0.05
tStatistically significant p S 0.01
Table 5. Incidence of nephropathy in male rats.a,b
was no associated pathological change in the liver, even
at the ultrastructural level. The absolute kidney weight No. ofanimals affected
and the relative weight were increased in male rats Finding 0 ppm v/v 1000 ppm v/v 8000 ppm v/v
exposed to8000ppmv/vfor2years. This wasassociated Number examined 100 (45) 100 (50) 100 (31)
with a more severe nephrosis compared with control Nephropathy
males (Table 5), and some slight evidence offunctional None 13 (4) 25 (7) 9 (0)
change were reflected in the amount of protein in the Minimal 29 (12) 32 (20) 11 (1)
urine. Itispossiblethatthehigherrelative heartweight Moderate 10 (7) 7 (4) 11 (2)
in the same group may have been related to blood pres- Marked 3 (2) 3 (2) 14 (9)
sure changes resulting from the developing kidney Severe 7 (1) 6 (1) 13 (2)
changes. 'The figures in parentheses are the values for animals killed at the
There werehigherrelative lungand spleenweights in end ofthe study.
the high-dose males at 2 years. In the same males there bA statistically significant dose-related trend (p < 0.05) for fatal
s a h e incidence of focal epithelialization (meta- nephropathy was established. "Fatal" was defined for the statistical was a higher mcaneO oa ptellzto mt- treatment by the Peto method of analysis.
plasia) in the lungs (5/45 for controls compared with
10/31 forhigh-dosemales killed atthe end ofthestudy). exocrineadenomainhigh-dosemaleswasincreased(p S
Some tumors were present in larger numbers in the 0.001). For females, uterine sarcoma showed a signifi-
treated animals than in the controls; those with statisti- cant(p
- 0.05)treatment-relatedtrend, butthenumbers
cally increased incidences are shown in Table 6. Com- in both treated groups were similar (1 compared with 4
pared with the controls, the incidence of pancreatic or 5). Zymbal gland carcinoma was confined to the high
Table 6. Total incidence of tumors at selected sites.
Male Female
Tissue and tumor 0 ppm v/v 1000 ppm v/v 8000 ppm v/v 0 ppm v/v 1000 ppm v/v 8000 ppm v/v
Pancreas
Exocrine adenoma 3 1 10 2 0 0
Uterus
Sarcoma 1 4 5
Zymbal gland
Adenoma 1 1 1 0 0 0
Carcinoma 0 0 1 0 0 4
Mammary gland
Benign 0 2 0 32 64 55
Malignant 1 0 0 18 15 26
Total 1 2 0 50 79 81
Thyroid
Follicular-cell adenoma 3 5 1 0 2 10
Follicular-cell carcinoma 1 0 0 0 2 1
Testis
Leydig cell tumor 0 3 8
Total number oftumor-bearing rats 84 70 87 97 98 94
Subtotal tumor-bearers
No tumors 16 30 13 3 2 6
Single tumors 26 32 30 41 24 17
Multiple tumors 58 38 57 56 74 77
Numbers of rats examined 100 100 100 100 100 100
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dose, with a significant (p
- 0.01) treatment-related
trend in females (O compared with 4). The incidence of
the total mammary gland adenoma and carcinoma in
females wasincreased toasimilarextentinbothtreated
groups with a significant (p
- 0.001) dose-related trend
(50 compared with 79 or 81). A significant trend (p
-
0.01) was present in females for thyroid follicular-cell
adenoma(Ocomparedwith2and 10). Leydigcelltumors
showed a dose-related increase in incidence (p
- 0.001)
(O compared with 3 and 8 for the low- and high-dose
groups, respectively).
It is possible that not all of the lesions classified as
pancreaticadenomawereneoplasticsincethedistinction
between adenoma and the hyperplastic focus or nodule
inthis organ is not clear. The more severe classification
was chosen but, in view ofthe debatable nature ofthe
lesion, the increase-confined to one sex-was con-
sidered as doubtful biological evidence ofoncogenicity.
Thenumbersofuterine sarcomasandofZymbalgland
tumors were similar to those nornally found in un-
treated Sprague-Dawley rats at Hazelton Laboratories
and do not suggest, in isolation, a treatment-related
effect. MostoftheZymbalglandtumorswerepresentin
animalskilledinashortperiod(76to90weeks), andnone
were found at the end of the study. If this cluster of
tumors, found relatively early in the exposure period,
was due to direct chemical action, it would be expected
that others would be found later in the experiment. In
the absence of such a time-related effect, it seems un-
likely that the Zymbal gland tumors are due to treat-
ment. Themammaryglandtumorsappeared earlierand
in greater numbers inthe treated females, suggesting a
relation to treatment. The higher numbers of thyroid
and testis tumors also are considered to be treatment
related, although the highest incidence oftestis tumors
at the highest dose was close to the historical control
range (0% to 6%) seen at Hazelton Laboratories.
It is felt that the effect of1,3-butadiene is more likely
tobe asanindirecteffectthroughtheendocrine system,
ratherthanadirect effectfromthereactive epoxideand
diepoxide metabolites. The reasoning behind this opin-
ion is that ifthe action was simplythroughthe epoxides
and diepoxides, then one would expect to see more
activity on the liver, whereas in this study the liver
suffered only minor changes in weight. Changes in the
mammary and pancreatic tumor profiles indicate in-
volvement ofthe endocrine system.
In summary, following exposure to 1,3-butadiene,
there were no effects on hematology, blood chemistry,
urine analysis, and neuromuscular function that defi-
nitely could be associated with treatment. Treatment
was associated with changes in clinical condition, sup-
pression of body weight gain, reduced survival, in-
creases in the weight ofcertain organs, and increases in
bothcommonanduncommontumortypes. Althoughthe
biological interpretation of the significance of some of
thetumortypesisequivocal, theevidence suggests that
the test article is a weak oncogen to the rat under the
conditions ofexposure used inthis study, andthe mech-
anism is more likely to be an indirect effect through the
endocrine system, rather than a direct effect through
the production of reactive metabolites.
This studywasorganized bythe International Institute ofSynthetic
RubberProducers Inc. (IISRP)andfundedbytheusersandproducers
of 1,3-butadiene worldwide. We are indebted to the IISRP for per-
mission to publish this paper.
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